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Abstract
Background: The purpose of this study was to provide a reference of chronic diabetes complications by investigating
the prolonged hyperglycemia effects on hematological, biochemical and histopathological changes (liver, kidney,
spleen, cardiac muscle, adrenal gland, and endocrine pancreas) in diabetic rats induced by streptozotocin. Methods:
Ten adult female Sprague-Dawley of uniform age were divided into two Groups. Group 1 was made diabetic by single
intraperitoneal injection of streptozotocin (60 mg/kg/bw) whereas Group 2 served as control. After six months, the rats
were anaesthetized using pentobarbital. Cardiac puncture was performed to get 3 ml of the blood sample; following 12
hours of an overnight fast. Serum chemistry test and complete blood analysis for lipid profile and blood glucose test;
liver and renal functions were performed. Tissue specimens of liver, kidney, spleen, cardiac muscle, adrenal gland, and
endocrine pancreas were fixed in 10% formal saline and processed for histological study. Results: There were severe
histopathological changes in the affected organs; and the presence of a significant abnormality of lipid profile, liver, and
renal functions. Conclusions: The presence of histopathological changes with abnormal biochemical changes is related
to the chronic absence of insulin production in the destroyed β–cells which reflect the diabetic complications in a
human being.
Keywords: biochemical, histopathological, rats, streptozotocin

diabetes induction in animals, mild to severe diabetes
are generated depending on the animal strain, dose, period
and route of drug administration.3 A single intraperitoneal
injection of STZ (150 mg/Kg body weight) or multiple
intraperitoneal injections of low dose (40 mg/Kg body
weight) in mice produced a significant hyperglycemia
similar to a type 1 diabetic. Mild diabetes, characterised
by low glycemic intensity, was induced in rats received
100mg/kg STZ injection subcutaneously.4,5 Mild diabetes
was also observed in rats injected intraperitoneally with
a single dose of 100mg/kg of STZ.6,7 It was found that a
single i.p. Injection of 100 mg/kg STZ in mice produced
non-insulin-dependent DM characterised by impaired
insulin response to glucose stimulation while 200 mg/kg
STZ-induced insulin-dependent DM.8 The purpose of
this study was to provide a reference of chronic diabetes
complications by investigating the prolonged complications
of untreated diabetes on hematological, biochemical and
histopathological changes (liver, kidney, spleen, cardiac
muscle, adrenal gland, and endocrine pancreas) in untreated
diabetic rats after six months of treatment with STZ.

Introduction
Diabetes mellitus (DM) is the commonest metabolic
diseases characterised by hyperglycemia resulting from
deficiencies in insulin secretion or action or both; that
affects carbohydrate, lipid, protein and nucleic acid
metabolism. According to the international diabetes
federation (IDF), more than 382 million adults throughout
the world suffered from diabetes, and 5.1 million deaths
occur yearly due to diabetes.1 The frequency of diabetes
has doubled in the last three decades, and it is predicted
to continue rising to 592 million cases by 2,035.1
Experimental models of diabetes have been developed
by using drugs such as Streptozotocin (STZ) to induce
diabetes. These drugs inflate and ultimately destruct the
β-cells of the pancreatic islets. STZ is an antimicrobial
agent; initially developed as an antibiotic and antitumor
agent.2 It is now widely used to induce diabetes mellitus
in many animal species resembling many features seen in
human patients’ condition including clinical, physiological
and pathological features. STZ is the first choice for
48
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Methods
Animals and experimental design. Ten adult female
Sprague-Dawley rats (weighing 200-225 g, 12 weeks
old) were used. All experimental rats were kept in cages
under the standard laboratory conditions (adequate cross
ventilation; temperature: 22 ± 1 °C; 12:12 hrs light: dark
cycle; relative humidity: 60-70%) and were allowed one
week period to acclimatise before the experiment. The
rats were maintained on standard commercial dry pellet
diet and water ad libitum. The rats were randomly
divided into two groups of 5 animals, control group and
STZ treated group. STZ (Merck) was dissolved in 0.1M
citrate buffer PH 4.5 immediately before i.p. Injection.
Following an overnight fast, diabetes was induced under
light anaesthesia (Sodium pentobarbital) by a single
intraperitoneal injection of 60 mg/kg of STZ. Rats were
supplied with 5% glucose solution for 24 hrs.
Immediately after STZ injection to prevent the severe
acute hypoglycemic effect. The rats of the control group
received an equivalent volume of i.p injection of Citrate
Buffer only. Three days post induction, fasting blood
glucose level was measured, only rats with fasting blood
sugar (FBS) level ≥ 15 mmol/L were considered as
diabetic rats.
Collection of blood samples and biochemical assays.
All rats were anaesthetized with pentobarbital (90
mg/kg). The blood samples (3 ml) of each animal were
withdrawn by cardiac puncture; following an overnight
fast for 12 hrs. All blood samples preserved with
suitable blood tube with specific agents. Serum
chemistry test and complete blood analysis were
performed in Biochemistry and Hematology Unit
(Faculty of Medicine, International Islamic University
Malaysia).
Histological studies. After six months, fasting blood
glucose level was measured, animals from control and
treated groups (STZ) were sacrificed by using mild
anaesthesia (Sodium pentobarbital 90 mg/kg); dissected
and small pieces of different organ (Pancreas, liver,
kidney, spleen, cardiac muscle and adrenal gland) were
quickly removed, fixed in 10% formal saline for 72 hrs.,
dehydrated through graded alcohols and processed for
light microscopy. Sections of (4-5 µ thickness) were
stained with Ehrlich Haematoxylin and Eosin.
Statistical analysis. Data analyses were performed
using statistic software IBM SPSS Statistics 20 (IBM
Corporation, NY, USA). All data in this study are
presented as mean ± SEM. Data were analysed by
Mann-Whitney U test, the value of p < 0.05 was
considered significant.
All experimental protocols involving animals and their
care were approved by the institutional animal care and
used committee of International Islamic University
Makara J. Health Res.

Malaysia (Ref. no. 2015-6-34-IACUC-IIUM/) and the
experimental protocols followed the “Guide for the care
and use of laboratory animals”.9

Results
Liver function tests. The changes in the liver function
profile of diabetic and Non-diabetic rat are illustrated in
Table 1. The result shows a significant reduction in total
protein and albumin level in the serum of diabetic rats.
The serum level of ALP, ALT, AST, as well as total
bilirubin, was significantly higher in the diabetic rats
group compared with control group.
Lipid profile and blood glucose test. Table 2 showed
the lipid profile and blood glucose of diabetic and Nondiabetic rat. Lipid profile of diabetic rats was
characterised by an extremely significant elevation (p <
0.01) in the levels of low-density lipoprotein (LDL) and
triglyceride (TG), compared with the normal animals.
The high-density lipoprotein (HDL) level is slightly
decreased in the diabetic group, but it was not
statistically significant (p > 0.05). Fasting glucose sugar
(FBS) level increased significantly in the diabetic group
(p < 0.01), compared with control group.
Kidney function tests. The renal function parameters of
diabetic and Non-diabetic rat are illustrated in Table 3.
Renal profile of diabetic rats was characterised by a
significant decrease in calcium, chloride and sodium
serum level compared with control group (p < 0.05).
While serum urea concentration showed a significant
increase (p < 0.05) in STZ-diabetic rats.
Hematological tests. The hematological profile of
diabetic and normal rats are illustrated in Table 4. Red
blood cell (RBC) count of the diabetic group showed a
significant decrease (p < 0.05) compared with control
group. The significant decline (p < 0.05) in the levels of
mean corpuscular haemoglobin concentration (MCHC)
and corpuscular Hb concentration mean (CHCM) were
noted in diabetic rats. In contrast, there is a significant
increase (p < 0.05) in the levels of mean corpuscular
volume (MCV), mean corpuscular haemoglobin (MCH)
and cellular haemoglobin (CH) was observed in the
diabetic animals. About White blood cell (WBC), the
present data showed a significant decrease (p < 0.05) in
STZ treated group when compared with control group.
On the other hand, there was a substantial increase (p <
0.05) in Neutrophils (NEUT) and Monocytes (MONO).
On the contrary, Lymphocytes (LYMP) and Leucocytes
(LUC) showed a significant decrease (p < 0.05) when
compared with normal control group.
Histological observation. The normal histological
structure of the pancreas is observed in (Figure. 1A); the
pancreatic islet cells are embedded within the acinar
cells and surrounded by a fine capsule. The pancreatic
August 2016 | Vol. 20 | No. 2
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islets of diabetic rats revealed severe pathological
changes. The STZ pancreas showed destructed
pancreatic islets with severe atrophy and massive loss of
islet cells leading to large cytoplasmic vacuoles; some
vacuoles are filled with a semifluid-like material and
dilated sinusoids with eosinophilic material deposition.
The pathological changes also extended into
surrounding exocrine tissue. The size of the exocrine
cells was shrunken with the occurrence of peripheral
widening between pancreatic acinar and islet cells

(Figure 1B). Microscopical examination of liver
sections from the control rats showed normal
architectures of the hepatocytes with distinctive central
veins (Figure 1C). On the other hand, liver sections of
the STZ treated group showed dilated and congested
sinusoid with mild free (hemorrhage) RBC in the
interstitial tissue, centrilobular necrosis, infiltration of
inflammatory cells, deposition of amyloid material and
fibrosis surrounding the portal tried (Figure 1C).

Table 1. Liver Function Tests of the Experimental Groups

Parameters
Total protein (g/L)
Albumin (g/L)
ALP (U/L)
ALT (U/L)
AST (U/L)
Total bilirubin (umol/L)
Direct bilirubin (umol/L)
Indirect bilirubin (umol/L)

None- diabetic group (Control)
74.00 ± 1.52
40.45 ± 1.53
73.35 ± 3.78
51.44 ± 4.65
144.84 ± 8.80
0.94 ± 0.12
0.68 ± 0.10
0.28 ± 0.07

Diabetic group (STZ group)
65.80 ± 2.08**
25.61 ± 2.59**
606.02 ± 261.37**
127.80 ± 10.44**
193.53 ± 12.20*
2.23 ± 0.70*
1.36 ± 0.40
0.86 ± 0.35

Data are presented as mean ± SEM and Mann-Whitney U test is used, p < 0.05 is taken as statistically significant at a 95% confidence interval.
*significant (p < 0.05), **high significant (p < 0.01)

Table 2. Lipid profile & Fasting Blood Sugar (FBS) Tests of the Experimental Groups

Parameters (mmol/L)
LDL
HDL
TG
TC
FBS

Non- diabetic group (Control)
0.22 ± 0.04
1.73 ± 0.09
0.51 ± 0.02
2.02 ± 0.10
3.90 ± 0.08

Diabetic group (STZ group)
0.90 ± 0.42**
1.36 ± 0.14
1.31 ± 0.32**
1.78 ± 0.15
29.62 ± 1.06**

Data are presented as mean ± SEM and Mann-Whitney U test is used, p < 0.05 is taken as statistically significant at a 95% confidence interval. **high
significant (p < 0.01)

Table 3. Kidney Function Tests of the Experimental Groups

Parameters
Creatinine (umol/L)
Uric acid (umol/L)
Urea (mmol/L
Calcium (mmol/L)
Chloride (mmol/L)
Potassium (mmol/L
Sodium (mmol/L)
Phosphate (mmol/L)

Non- diabetic group (Control)
26.94 ± 2.12
82.80 ± 12.08
5.45 ± 0.71
2.42 ± 0.10
102.53 ± 0.55
4.81 ± 0.21
138.88 ± 0.24
2.10 ± 0.07

Diabetic group (STZ group)
25.23 ± 1.71
79.11 ± 9.49
13.18 ± 2.85*
2.12 ± 0.065*
91.02 ± 1.53*
5.25 ± 0.39
133.48 ± 1.52*
1.87 ± 0.19

Data are presented as mean ± SEM and Mann-Whitney U test is used, p < 0.05 is taken as statistically significant at a 95% confidence interval.
*significant (p < 0.05).
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Table 4. Hematological Tests of the Experimental Groups

Parameters
RBC (10^12 /L
HGB (g/d L)
HCT (%)
MCV (f L)
MCH (pg)
MCHC (g/d L)
CHCM (g/d L)
CH (pg)
RDM (%)
HDW g/d L)
PLT (10^9 /L)
MPV (f L)
WBC (10^9 /L)
NEUT (%)
LYMP (%)
MONO (%)
EOS (%)
BASO (%)
LUC (%)

None- diabetic group (Control)
8.39 ± 0.21
14.45 ± 0.41
44.62 ± 0.97
53.25 ± 0.25
17.28 ± 0.10
32.43 ± 0.30
33.48 ± 0.43
17.78 ± 0.17
12.70 ± 0.12
2.32 ± 0.02
1389.50 ± 45.98
7.40 ± 0.07
16.40 ± 2.07
4.35 ± 0.48
65.38 ± 2.96
14.50 ± 1.11
4.08 ± 1.87
0.28 ± 0.06
11.43 ± 0.33

Diabetic group
7.17 ± 0.47*
13.23 ± 1.04
42.45 ±3.40
59.00 ± 1.41*
18.38 ± 0.43*
31.18 ± 0.21*
32.03 ± 0.38*
18.78 ± 0.50*
15.60 ±1.17
2.52 ± 0.28
594.00 ± 66.68*
7.43 ± 0.25
4.54 ± 0.65*
20.75 ± 3.47*
31.10 ± 8.35*
39.83 ± 4.76*
0.85 ± 0.56
0.55 ± 0.45
6.98 ± 1.03*

Data are presented as mean ± SEM and Mann-Whitney U test is used, p < 0.05 is taken as statistically significant at a 95% confidence
interval. *significant (p < 0.05).

Figure 1. Photomicrographs of Sections of: A). Pancreas of Control Group, Showing Normal Histological Structure. B).
Pancreas of STZ Treated Rats, Showing Severe Atrophy and Massive Loss of Islet Cells, Large Cytoplasmic
Vacuoles (v), Dilated Sinusoids with Eosinophilic Material Deposition (Arrow), and Degeneration Extends to
Exocrine Acinar Cells (Curved Arrow). C). Liver of Control Group, Showing Normal Architecture. D). Liver of
STZ Treated Rats, Showing Centrilobular Necrosis (Arrow), Kupffer Cells Infiltration (Head Arrow), Lymphocytic
Infiltration and Fibrosis Near the Portal Tried (pt), Amyloid Material and Fibrosis Near the Portal Tried (Curved
Arrow) (H&E x 200)
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The kidney of control rats showed normal histological
structures of the glomeruli, and renal tubules (Figure.
2A). The kidney sections of diabetic rat exhibited
tubular damage with fatty degeneration, dilated tubular
lumen lined with degenerated epithelium and apoptotic
cells, congested blood vessels, shrunken glomeruli,
widening of Bowman space, thickening of the arterial
wall, and periarterial mononuclear infiltration (Figure. 2
B&C). Sections of the wall of the heart of the of control
rats showed normal histological appearance. The
myocardium showed branching, anastomosing cylinders
myocardium with centrally located oval basophilic
nuclei (Figure. 2D). The myocardium of STZ rat
revealed histological changes in the form of
disorganisation,
distortion,
degeneration
and
hyalinization of the myocardial fibers, increased
interstitial space with chronic inflammatory infiltration,
thickened vascular wall, dilated and congested blood
vessels with eosinophilic material deposition (Figure.

2E). The spleen of control rats showed normal white
and red pulp and with distinctive marginal zone (Figure.
3A). Examination of STZ diabetic rat’s spleen sections
revealed degeneration of the marginal zone of the white
pulp. In addition to apoptosis and necrosis of
lymphocytes in the red and white pulps, a decrease in
the lymphocytes and macrophages in the germinal
centre, and thickening of the central arteriolar wall,
congested and distended venous sinuses and amyloidlike material deposition and fibrosis in red and white
pulps (Figure. 3 B&C). The adrenal glands of control
rats revealed normal appearance and
were seen
surrounded by thin connective tissue capsule (Figure.
3D). Sections of STZ diabetic rat’s adrenal glands
showed severe hydropic degenerative and pycnotic
changes in zona glomerulosa and zona fasciculate,
dilated and congested sinusoids in the cortex, thickened
capsule and blood vessel wall and lobulation and
fibrosis in the cortex (Figure. 3E).

Figure 2. Photomicrographs of Sections of: A; Kidney of Control Group, Showing Normal Histological Structure. B and C;
Kidney of STZ Treated Rats, Showing Shrunken Glomeruli, Dilated Bowman Space (s), Dilated Lumen of PCTs
Lined with Degenerated Epithelium with Apoptotic Cells (Arrow), Abnormal Renal Tubules with Fatty
Degeneration (f) and Mononuclear Infiltration(Curved Arrow). D; Myocardium of Control Group, Showing
Normal Architecture. E; Myocardium of STZ Treated Rats, Showing Degeneration of the Myocardial Fibers
(Arrow), Increased Interstitial Space(s), Dilated and Congested Blood Vessels with Eosinophilic Material
Deposition (Curved Arrow). (H&E x A, B, C &D; 200, E; 400)
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Figure 3. Photomicrographs of Sections of: A; Spleen of Control Group, Showing Normal Histological Structure. B and C;
Spleen of STZ Treated Rats, Showing Congestion of Splenic Tissues with Markedly Distended Venous Sinuses
(Arrows). Amyloid-like Material Deposition (Head Arrows), Degeneration of the Marginal Zone, Apoptosis and
Necrosis of Lymphocytes in the Red and White Pulps (Stars). Decline in the Number of Macrophages and
Lymphocytes in the Germinal Center (g), and Thickening of the Central Arteriolar Wall. D; Adrenal Gland of
Control Group, Showing Normal Architecture. E; Adrenal Gland of STZ Treated Rats, Showing Severe Hydropic
Degenerative Changes in Zona Glomerulosa and Zona Fasciculate (Arrows), Thickened Capsule and Blood Vessel
Wall (Curved Arrow) and Lobulation and Fibrosis in the Cortex. (H&E x A, B, &D; 200, C&E; 400)

Discussion
Diabetes mellitus is a metabolic disease distinguished
by numerous groups of disorders that disturb the
metabolism of carbohydrates, fat, and protein.10 In the
present study, diabetes induced by STZ was associated
with many complications. These complications include
dyslipidemia, electrolyte imbalance, hepatic enzymes
disturbance and hematological abnormalities. Diabetes
induced by STZ has been related to abnormal lipid
profile. The increases in plasma triacylglycerol and lowdensity lipoprotein (LDL), and the decrease in highdensity lipoprotein (HDL) indicated significant
dyslipidemia in diabetic rats; similar results were
obtained by several studies in human and experimental
diabetes.11,12 Some biochemical mechanisms have been
suggested as responsible for the hypertriglyceridemia in
diabetes. These include an increase in the activity of
hormone-sensitive lipase, which catalyses the
mobilisation of fatty acids from triacylglycerol stored in
adipocytes.13,14 Therefore, the larger amounts of fatty
Makara J. Health Res.

acids returning to the liver are reassembled into
triacylglycerols and secreted in VLDL. It has
additionally been reported that the activity of
lipoprotein lipase is reduced in diabetes, and this
explained the diabetic hypertriglyceridemia.12
Hepatic enzymes level of AST, ALT, and ALP were
higher in the STZ diabetic rats. STZ has been noticed to
have a significant role in the alteration of liver
function.15 Associated with the progress of diabetes, a
state of decreased total protein concentration is
evidenced, which may have resulted from either
hyperfiltration induced diabetic nephropathy and/or
increased protein catabolism.16
In the present study, diabetes was associated with
electrolyte imbalance, where a decrease in serum Na,
Ca, and Cl, with increased serum K were recorded, this
might be due to the osmotic diuresis produced by the
state of hyperglycemia that causes marked urinary loss
of water and electrolytes.17 Concerning sodium,
August 2016 | Vol. 20 | No. 2
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additionally, there is a translocation of Na+, K+-ATPase
pumps from the basolateral membrane of proximal
convoluted tubules to the cytosol, which leads to a
decrease in sodium pumping from renal tubules to the
blood.18 As for serum calcium, previous studies
demonstrated lower concentration level associated with
a reduction in the mineral content of bone and increased
urinary excretion of calcium and phosphate in STZ
diabetic rats. The decrement of calcium was related to
several factors such as metabolic changes including
chronic acidosis; insulin deficiency, impaired
parathyroid hormone action and changed vitamin D
metabolism have been implicated.19 The urea level,
which has been considered as a significant marker of
diabetic nephropathy was increased in the STZ-induced
diabetic group, and this result is consistent with the
other study.20 It has been proved that the metabolic
defects observed in uncontrolled diabetes lead to
gluconeogenesis and consequently urea production.12
This previous result is consistent with the reduction in
the total serum protein level of diabetic rats in the
present study.
Hematological evaluations revealed significant (p <
0.05) decline in the red blood cell (RBC) values in
diabetic rats. These observations agree with existing
literature that anemia is a common pathophysiology
associated with diabetes mellitus.21 Recurrent or
persistent hyperglycemia during diabetes causes nonenzymatic glycosylation of body proteins. Some
biomolecules, such as Hb and RBC membrane proteins,
are modified by glycation. RBC membrane hemolysis is
due to the glycosylation of membrane proteins and lipid
peroxidation, and this may lead to anemia.22 The reduced
levels of WBC, PLT, and LYMP in diabetic rats
indicate suppression of the immune system. These cells
have an important role in identifying and eliminating
pathogens, either by attacking larger pathogens through
contact or by phagocytosis. They have the essential part
of the innate immune system, which is also an important
mediator of the activation of the adaptive immune
system.23 In addition to the previously mentioned, there
are many abnormalities regarding MCV, MCH, CH,
MCHC, CHCM, NEUT, MONO, and LUC. Diabetes
mellitus is responsible for the abnormalities in the
function, metabolism, and morphology of blood cells as
well as the coagulation system. Numerous abnormalities
are the consequence of hyperglycemia and protein
glycosylation. Even though they are not frequent
manifestations of diabetes, hematologic complications
can result in anemia, infection, and hypercoagulability.
Most hematologic deviations are reversible with effective
metabolic control.24
Histologically, STZ is well known for its selective
pancreatic islet β-cell cytotoxicity and has been
extensively used to induce diabetes mellitus in animals.
It interferes with cellular metabolic oxidative
Makara J. Health Res.

mechanisms. The decrease in cellularity within islets of
Langerhans observed in the present study reflects the
cytotoxicity of STZ.25 STZ treatment in rats exhibited
shrunken islets of Langerhans with cytoplasmic
vacuolation of their cells associated with negative
insulin immunoreaction; ultrastructurally the β-cells
showed darkly stained nuclei with marked loss of
granules.26 The pathoanatomical changes in liver of
diabetic animals have been previously reported.27,28
Liver, an insulin-dependent tissue, playing a pivotal role
in glucose and lipid homeostasis, is severely affected by
diabetes.29 Previous studies have detected moderate to
severe degeneration of the hepatocytes.6 The structural
changes in kidneys could be attributed to altered
metabolism in diabetes and the subsequent effects on
the increased renal threshold for hyperglycemia.30
Previous studies on the long-term effects of diabetes in
experimental animals show glomerular nephropathy
along with tubular and interstitial abnormalities. 31
Massive inflammatory infiltrates in the interstitial tissue
as well as vacuolar degeneration of tubular epithelial
cells and renal glomeruli.30,32 The anomaly in the
cardiac muscle in the present study is consistent with
the earlier animal study, which demonstrated severe
necrotic cardiac muscle in STZ diabetic rats. Previous
observation by an electron microscope showed the
disappearance of the myofilaments organisation and
pyknic mitochondria in the myocardium of diabetic
rats.33 The histopathological changes in heart could be
attributed to the subsequent effects of hyperglycemia
which induces degenerative changes in the tissues along
with cardiomyopathy and nephropathy by oxygen free
radicals.34 The abnormalities in the zona glomerulosa
and zona fasciculate in addition to the cortical fibrosis
and thickened blood vessel wall of the adrenal gland in
this study could be attributed to the hormonal changes
as mentioned by the previous investigation.35 In the
present study, the diabetic rats exhibited numerous
abnormal histopathological features of the spleen
characterised by apoptosis of the lymphocyte and
necrosis in the white, and red pulps are consistent with
the previous observation that demonstrated extensive
parenchymal fibrosis involving the marginal zone and
follicular areas of the white pulp.36

Conclusions
This research regards as a comprehensive study of
diabetes complications in an animal model. After six
months, STZ-diabetic rats showed severe pathological
changes in the Islets of Langerhans, liver, kidney, spleen,
cardiac muscle and adrenal gland. These pathological
changes associated with the deterioration of the liver
and renal functions, lipid profile, and haematological
parameters. On the other hand, this study can be used as
a reference for many biochemical and histopathological
abnormalities of diabetes complications in an animal
model for other researchers. The results of this research
August 2016 | Vol. 20 | No. 2
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can be used in studies which looking at the treatment of
diabetes complications for comparison purposes.
Researchers recommend following the method of
diabetes induction which has been used because they
showed excellent results.
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